|
84
|
292
|
4o0tA |
Back pocket flexibility provides group-ii pak selectivity for type 1 kinase inhibitors |
|
84
|
273
|
4n6zA |
Pim1 complexed with a pyridylcarboxamide |
|
154
|
465
|
4mx9A |
Cdpk1 from neospora caninum in complex with inhibitor uw1294 |
|
74
|
228
|
4o7rA |
Saicar synthetase (type-2) in complex with ump/udp |
|
86
|
298
|
4nksA |
Crystal structure of human fibroblast growth factor receptor 1 kinase domain in complex with pyrazolaminopyrimidine 3 |
|
90
|
263
|
4otqA |
Crystal structure of btk kinase domain complexed with 1-[5-[3-(7-tert-butyl-4-oxo-quinazolin-3-yl)-2-methyl-phenyl]-1-methyl-2-oxo-3-pyridyl]-3-methyl-urea |
|
113
|
352
|
4nifB |
Heterodimeric structure of erk2 and rsk1 |
|
111
|
329
|
4oucA |
Structure of human haspin in complex with histone h3 substrate |
|
88
|
335
|
4otiA |
Crystal structure of prk1 catalytic domain in complex with tofacitinib |
|
112
|
347
|
4nctA |
Human dyrk1a in complex with pkc412 |
|
80
|
279
|
4o6lA |
Crystal structure of ttk kinase domain with an inhibitor: 401498 (n-[(1r)-1-(2-chlorophenyl)propyl]-3-{4-[(1-methylpiperidin-4-yl)oxy]phenyl}-1h-indazole-5-carboxamide) |
|
98
|
331
|
4nstA |
Crystal structure of human cdk12/cyclin k in complex with adp-aluminum fluoride |
|
71
|
233
|
4o7nA |
Saicar synthetase (type-2) in complex with adp |
|
74
|
228
|
4o7yA |
Saicar synthetase (type-2) in complex with cmp |
|
108
|
361
|
4nm5A |
Crystal structure of gsk-3/axin complex bound to phosphorylated wnt receptor lrp6 c-motif |
|
107
|
299
|
4orkA |
Crystal structure of the phosphotransferase domain of the bifunctional aminoglycoside resistance enzyme aac(6')-ie-aph(2'')-ia |
|
109
|
346
|
4nctC |
Human dyrk1a in complex with pkc412 |
|
77
|
232
|
4o7wA |
Saicar synthetase (type-2) in complex with atp and tdp |
|
85
|
343
|
4ntsA |
Apo structure of the catalytic subunit of camp-dependent protein kinase |
|
97
|
336
|
4otdA |
Crystal structure of prk1 catalytic domain |
|
96
|
330
|
4nh1A |
Crystal structure of a heterotetrameric ck2 holoenzyme complex carrying the andante-mutation in ck2beta and consistent with proposed models of autoinhibition and trans-autophosphorylation |
|
79
|
275
|
4n70A |
Pim1 complexed with a pyridylcarboxamide |
|
75
|
227
|
4o86A |
Saicar synthetase (type-2) in complex with adp and cdp |
|
95
|
306
|
4o91A |
Crystal structure of type ii inhibitor ng25 bound to tak1-tab1 |
|
86
|
302
|
4nt4A |
Crystal structure of the kinase domain of gilgamesh isoform i from drosophila melanogaster |
|
74
|
228
|
4o7vA |
Saicar synthetase (type-2) in complex with adp and udp/ump |
|
75
|
225
|
4o7tA |
Saicar synthetase (type-2) in complex with adp, asp and tmp |
|
82
|
277
|
4mxoA |
Human src kinase bound to kinase inhibitor bosutinib |
|
147
|
455
|
4mvfA |
Crystal structure of plasmodium falciparum cdpk2 complexed with inhibitor staurosporine |
|
79
|
277
|
4mxzA |
Src m314l t338m double mutant bound to kinase inhibitor bosutinib |
|
79
|
277
|
4mxyA |
Src m314l t338m double mutant bound to kinase inhibitor bosutinib |
|
155
|
465
|
4mxaA |
Cdpk1 from neospora caninum in complex with inhibitor rm-1-132 |
|
98
|
295
|
4mxcA |
Crystal structure of cmet in complex with novel inhibitor |
|
82
|
272
|
4ll5A |
Crystal structure of pim-1 in complex with the fluorescent compound skf86002 |
|
159
|
464
|
4m84A |
Calcium-dependent protein kinase 1 from toxoplasma gondii (tgcdpk1) in complex with inhibitor uw1455 |
|
81
|
286
|
4m7iA |
Crystal structure of gsk6157 bound to perk (r587-r1092, delete a660-t867) at 2.34a resolution |
|
84
|
263
|
4m15A |
Crystal structure of itk in complex with compound 9 [4-(carbamoylamino)-1-[7-(propan-2-yloxy)naphthalen-1-yl]-1h-pyrazole-3-carboxamide] and adp |
|
97
|
337
|
4mygA |
Mapk13, active form |
|
88
|
263
|
4m14A |
Crystal structure of itk in complex with compound 9 [4-(carbamoylamino)-1-[7-(propan-2-yloxy)naphthalen-1-yl]-1h-pyrazole-3-carboxamide] |
|
88
|
278
|
4mwiA |
Crystal structure of the human mlkl pseudokinase domain |
|
122
|
435
|
4lv7A |
Crystal structure of inositol 1,3,4,5,6-pentakisphosphate 2-kinase e82c/s142c |
|
91
|
317
|
4mneA |
Crystal structure of the braf:mek1 complex |
|
47
|
162
|
4lrkA |
Bacterial effector nleh2 kinase domain |
|
81
|
265
|
4mf1A |
Itk kinase domain in complex with benzothiazole inhibitor 12b (1s,2s)-2-{4-[(dimethylamino)methyl]phenyl}-n-[6-(1h-pyrazol-4-yl)-1,3-benzothiazol-2-yl]cyclopropanecarboxamide |
|
71
|
321
|
4ll0A |
Egfr l858r/t790m in complex with pd168393 |
|
77
|
273
|
4medA |
Crystal structure of ser/thr kinase pim1 in complex with thioridazine derivatives |
|
80
|
274
|
4mbiA |
Discovery of pyrazolo[1,5a]pyrimidine-based pim1 inhibitors |
|
85
|
278
|
4m67A |
Crystal structure of the human mlkl kinase-like domain |
|
84
|
264
|
4m12A |
Crystal structure of itk in complex with compound 7 [4-(carbamoylamino)-1-(7-ethoxynaphthalen-1-yl)-1h-pyrazole-3-carboxamide] |
|
82
|
273
|
4mtaA |
Crystal structure of pim-1 kinase domain in complex with 2-methyl-5-phenylfuran-3-carboxylic acid |
